Europe Randomization And Trial Supply Management (Rtsm) Market Size & Outlook
The randomization and trial supply management (rtsm) market in Europe is expected to reach a projected revenue of US$ 12,834.5 thousand by 2033. A compound annual growth rate of 15.1% is expected of Europe randomization and trial supply management (rtsm) market from 2026 to 2033.
- Healthcare IT
- Healthcare Information and Management Systems
- Randomization and Trial Supply Management (RTSM) Market Outlook
- Healthcare Information and Management Systems
Revenue, 2025 (US$K)
$4,189.9
Estimate, 2026 (US$K)
$4,782.4
Forecast, 2033 (US$K)
$12,834.5
CAGR, 2026 - 2033
15.1%
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the randomization and trial supply management (rtsm) market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Europe randomization and trial supply management (rtsm) market highlights
- The Europe randomization and trial supply management (rtsm) market generated a revenue of USD 4,189.9 thousand in 2025.
- The market is expected to grow at a CAGR of 15.1% from 2026 to 2033.
- In terms of segment, cloud and web-based was the largest revenue generating delivery mode in 2025.
- Cloud and web-based is the most lucrative delivery mode segment registering the fastest growth during the forecast period.
- Country-wise, Denmark is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 4,189.9 thousand |
| Market revenue in 2033 | USD 12,834.5 thousand |
| Growth rate | 15.1% (CAGR from 2026 to 2033) |
| Largest segment | Cloud and web-based |
| Fastest growing segment | Cloud and web-based |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD thousand |
| Market segmentation | Cloud and web-based, On-premise |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.7% of the global randomization and trial supply management (rtsm) market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Europe is the fastest growing regional market and is projected to reach USD 12,834.5 thousand by 2033.
No credit card required*
Publish Date: Apr 20, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Randomization And Trial Supply Management (RTSM) Market Scope
Randomization and Trial Supply Management (RTSM) Market segmentation & scope
Randomization And Trial Supply Management (RTSM) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Icon PLC | View profile | 41,150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | www.iconplc.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.parexel.com |
| Veeva Systems Inc Class A | View profile | 7,172 | 4280 Hacienda Drive, Pleasanton, CA, United States, 94588 | www.veeva.com |
| Medidata | View profile | 1001-5000 | New York, New York, United States, North America | www.medidata.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | www.almacgroup.com |
| Signant Health | View profile | 1001-5000 | Blue Bell, Pennsylvania, United States, North America | www.signanthealth.com/ |
| Mednet Healthcare Technologies | View profile | 501-1000 | Trenton, New Jersey, United States, North America | www.mednethealth.net |
| IQVIA | View profile | 10001+ | Danbury, Connecticut, United States, North America | www.iqvia.com |
| Clinion | View profile | 51-100 | Austin, Texas, United States, North America | www.clinion.com/ |
| Oracle | View profile | - | - | - |
Europe Randomization and Trial Supply Management (RTSM) Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Randomization and Trial Supply Management (RTSM) Market Outlook will help companies and investors design strategic landscapes.
Cloud And Web-Based was the largest segment with a revenue share of 103.66% in 2025.
Horizon Databook has segmented the Europe randomization and trial supply management (rtsm) market based on cloud and web-based, on-premise covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Randomization And Trial Supply Management (Rtsm) Market Delivery Mode Outlook (Revenue, USD Thousand , 2021-2033)
- Cloud and web-based
- On-premise
- Europe Randomization And Trial Supply Management (Rtsm) Market End Use Outlook (Revenue, USD Thousand , 2021-2033)
- Hospitals
- CROs
- Academic Institues
- Pharma & Biotech Organizations
- Medical Device Manufacturers
Reasons to subscribe to Randomization and Trial Supply Management (RTSM) Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Randomization and Trial Supply Management (RTSM) Market Outlook databook
- Our clientele includes a mix of Randomization and Trial Supply Management (RTSM) Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Randomization and Trial Supply Management (RTSM) Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Randomization and Trial Supply Management (RTSM) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Randomization And Trial Supply Management (Rtsm) Market, 2021-2033 (US$K)
Europe randomization and trial supply management (rtsm) market statistics, by delivery mode, 2021-2033 (USD Thousand)
